Arthur Braat

Research Staff Other

Strategic program(s):

Contact

abraat@umcutrecht.nl

Pure profile

Research groups

Endocrine oncology research group

Research aim

To improve diagnostics, treatment and outcome for children and adults with Rare Endocrine Tumors by interdisciplinary and international collaborative research.

Go to group

Primary Liver Tumors research group

Research aim

To improve surveillance, diagnostics, treatment, and outcome for patients with primary liver tumors (hepatocellular carcinoma and cholangiocarcinoma) by interdisciplinary and (inter-)national collaborative research

Go to group

Recent publications

All publications

Efficacy of Intra-arterial [¹⁷⁷Lu]Lu-DOTATATE monotherapy for treatment-refractory meningioma A. El Ghalbouni, T. J. Snijders, A. Amerein, N. Tolboom, M. Patt, C. J. Maurer, I. C. van der Schaaf, C. Lapa, A. J.A.T. Braat
Journal of Neuro-Oncology, 2026, vol. 176, p.1-9

Detection of Peritoneal Lesions of Hepatocellular Carcinoma Using [⁶⁸Ga]Ga-RAYZ-8009 Helen Scholtissek, Nic G. Reitsam, Bruno Märkl, Alexander Dierks, Ralph A. Bundschuh, Arthur J.A.T. Braat, Thomas Kröncke, Constantin Lapa
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025, vol. 66, p.1666-1667

Can non-tumorous liver tissue serve as a reliable reference measure for [¹⁸F]FDG-PET-CT after unilobar ⁹⁰Y glass radioembolization in patients with colorectal liver metastases? Li Shen Ho, Manon N.G.J.A. Braat, Guus Bol, Maarten L.J. Smits, Marnix G.E.H. Lam, Arthur J.A.T. Braat
EJNMMI Research, 2025, vol. 15

Integration of prostate-specific membrane antigen-PET and multiparametric MRI for gross tumour volume definition in localised and locally advanced prostate cancer treated with image-guided radiotherapy Tessa D van Bergen, Arthur J A T Braat, Cornelis A T van den Berg, Timo F W Soeterik
Current opinion in Urology, 2025, vol. 35, p.554-561

Radioembolization for neuroendocrine tumors Li Shen Ho, Tarik Baetens, Marnix G E H Lam, Arthur J A T Braat
Endocrine oncology (Bristol, England), 2025, vol. 5

PRRT plus holmium-166-SIRT (HEPAR PLuS) versus PRRT-only in patients with metastatic neuroendocrine tumors W B Veldhuis, T Walter, D M V de Vries-Huizing, J Theysohn, S Barton, E D Ekkelenkamp, B Lachachi, R J G de Jong, L W van Golen, H Lanzafame, L Milot, H Lahner, M E G H Lam, M E T Tesselaar, A J A T Braat
Journal of Neuroendocrinology, 2025, vol. 37